Related Experiment Video
Updated: Dec 6, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey
David C Cone1, Sandy Bogucki, Kevin Burns
1Department of Emergency Medicine, Yale School of Medicine, New Haven, CT (DCC, SB, KB, GD, KH, DJ, DAF); Program in Addiction Medicine, Yale School of Medicine, New Haven, CT (GD, KH, DAF); Yale School of Public Health, CT (GD, DAF); Department of Internal Medicine, Yale School of Medicine, New Haven, CT (DAF).
Objectives:
The COVID-19 epidemic in the United States has hit in the midst of the opioid overdose crisis. Emergency medical services (EMS) clinicians may limit their use of intranasal naloxone due to concerns of novel coronavirus infection. We sought to determine changes in overdose events and naloxone administration practices by EMS clinicians.
Methods:
Between April 29, 2020 and May 15, 2020, we surveyed directors of EMS fellowship programs across the US about how overdose events and naloxone administration practices had changed in their catchment areas since March 2020.
Results:
Based on 60 respondents across all regions of the country, one fifth of surveyed communities have experienced an increase in opioid overdoses and events during which naloxone was administered, and 40% have experienced a decrease. The findings varied by region of the country. Eighteen percent of respondents have discouraged or prohibited the use of intranasal naloxone with 10% encouraging the use of intramuscular naloxone.
Conclusions:
These findings may provide insight into changes in opioid overdose mortality during this time and assist in future disaster planning.
More Related Videos
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Cardiopulmonary Resuscitation IV: Pharmacological Management
Drug Delivery: Enteral Route
Opioid Analgesics: Morphine and Other Natural Cogeners
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Cardiopulmonary Resuscitation III: AED Use